Alpha SpotlightBack

796M and No Debt: POET Technologies Puts Its Cash to Work

Sponsored by POET Technologies Inc.6 min readMonday, October 5, 2026 at 12:32 PM ET
796M and No Debt: POET Technologies Puts Its Cash to Work

Share this article

Spread the word on social media

The war chest isn't idle. It's buying capacity, lasers, and the ramp its customers are waiting on.

POET Technologies POET Technologies (POET) closed June with $796.3 million in cash and short-term investments and zero debt. That's a pile of money for a company that booked $569,925 of revenue in the quarter. It's also the point. The $400 million May raise wasn't a rainy-day fund. It's going into capacity, R&D, lasers, and customer programs across the AI optical interconnect stack. The cash is the strategy.

Cash is a weapon in silicon photonics

Silicon photonics and co-packaged optics eat capital. Everyone in the space is racing to qualify optical engines at 800G, 1.6T, and 3.2T. Most are doing it while sweating the next raise. POET isn't. CEO Suresh Venkatesan said the May financing “removes the uncertainty associated with our staying power.” Translation: nobody at a qualification meeting has to ask if POET will still be around in 2028. That matters when customers and hyperscalers pick who they'll build around.

Run the burn. Operating cash outflow was $12.2 million in Q2. Call it $50 million a year, more once the ramp builds. Against $796 million, that's not a runway. It's a highway. And the cash earns its keep. Interest and other income came in at $4.3 million for the quarter. That covers a third of the burn before a single engine ships.

Where the $400 million goes

POET's filings earmark the proceeds for manufacturing capacity, R&D, the light source business, acquisitions and corporate development, and general expansion. The first four are the story.

1. Manufacturing capacity. The Lumilens order is the driver. POET's September investor deck pencils about $60 million of 2026 capex, with Penang assembly scaling from 1 million optical engines a year toward 10 million.

2. R&D. Spending hit $5.8 million in Q2, up from $4.5 million in Q1 and $3.1 million a year ago. POET calls it the move from tech development to product development. We call it building parts a customer can qualify: the 800G Infinity engines now shipping for qualification, the Teralight 1.6T and 3.2T chipsets in the Mitsubishi Electric program, and the engines inside Lessengers' 1.6T module.

3. Light sources. Blazar, POET's hybrid laser, just locked up an exclusive supplier for a component that significantly boosts its output power. After quarter-end came a deal with a Tier 1 laser company to co-develop an external light source engine.

4. Corporate development. POET took a 4.99% stake in Lessengers, about $3 million, on top of the 1.6T module Lessengers is building on POET engines. That turns a customer contract into a structural tie. Expect more of it.

CEO Dr. Suresh Venkatesan gave shareholders an update last week on some of the things we just discussed, you can listen to here.

The Lumilens Anchor

In May, Lumilens placed a $50 million initial purchase order for optical engines inside a framework that could top $500 million over five years. Engineering samples are targeted for late 2026. Lumilens isn't a lightweight, either. It raised more than $700 million in a Series C at a $5.51 billion valuation while still in stealth.

The deal structure tells you how both sides see it. POET granted Lumilens warrants on up to 22,921,408 shares at $8.25. About 2.3 million are exercisable now. The rest vest only as Lumilens pays toward future orders, up to that $500 million. POET booked the warrants at a $30.1 million fair value as deferred customer consideration. Read that twice. POET's spending $30 million of equity value to tie a customer's upside to volume. You only make that trade when you can afford to spend ahead of revenue.

That's the sequence the cash funds. Capex now. Qualification next. Production revenue when the samples pass.

The deal structure tells you how both sides see it. POET granted Lumilens warrants on up to 22,921,408 shares at $8.25. About 2.3 million are exercisable now. The rest vest only as Lumilens pays toward future orders, up to that $500 million. POET booked the warrants at a $30.1 million fair value as deferred customer consideration. Read that twice. POET's spending $30 million of equity value to tie a customer's upside to volume. You only make that trade when you can afford to spend ahead of revenue.

That's the sequence the cash funds. Capex now. Qualification next. Production revenue when the samples pass.

Capacity before the ramp, not after

POET runs its own assembly and test in Singapore and is building out Penang. Headcount went from 115 in May to 155 by late August. Mitsubishi Electric is a customer on the Teralight 1.6T program. Lessengers is another, building its 1.6T transceiver around POET engines. A cash-strapped fabless startup doesn't land those accounts. Customers pick suppliers that can finish what they start. Management says the production ramp is still on schedule for the second half of 2026, with substantial numbers of production units shipping for qualification through year-end.

Light sources are the sleeper

Co-packaged optics needs integrated, high-power, multi-wavelength light sources at scale. The industry is short on them and copper is too inefficient for the ramp. POET's treating Blazar as a product line, not a side project. The Tier 1 laser partner validates the external light source approach. At the June AGM, POET put Blazar on track for at-scale deployment in 2028. Cash is what lets a company carry a 2028 program while it funds a 2026 ramp.

What could slow the ramp

The risk isn't demand. It's whether the industry can build fast enough to meet it. Our supply chain analysis laid it out: 800G and 1.6T optical modules on lead times past 40 weeks, InP laser supply the chokepoint, capacity across the chain sold out. An AI cluster is a convoy. A slip anywhere shows up everywhere. POET's ramp rides that same convoy: lasers, substrates, assembly tools, test capacity. In this market, a missed ship date is usually the supply chain talking, not a company-specific red flag. Cash buys priority with suppliers. It doesn't buy time. Six straight quarters of sequential revenue growth say the engine's turning over. They don't say it's at speed.

Real talk

No debt. A $50 million order with a $500 million path. Capex going into the ground. R&D rising by design. A light source business with a Tier 1 partner. Can POET afford the jump from development-stage company to production-scale optical engine supplier? Yes, with room to spare. Whether it makes the jump is an execution question. The next two quarters of qualification shipments start answering it.

Want the next $POET read before the tape prices it? Subscribe to StockAlpha.ai.


POET TechnologiesPOET stock$POETsilicon photonics stocksco-packaged opticsAI optical interconnectoptical engines800G 1.6T optical enginesLumilens POETPOET customersAI photonics stocksPOET Technologies cashNASDAQ POETCNBC Fast Money

Trade this headline in Alpha Contests.

Free practice contests — earn Alpha Coins
Enter a Contest

Discover more insights

Get curated market analysis and editorial deep dives from our team. The stories that matter most, examined from every angle.

More Spotlight Articles

Compensation Disclosure: Jefferson Equity Derivatives & Intelligence LLC has been compensated for the promotion of POET Technologies Inc. (NASDAQ: POET). POET Technologies Inc. paid five hundred five thousand dollars ($505,000) USD Cash for a marketing program (March 1, 2026 through December 31, 2026). As a result, our opinion is neither unbiased nor independent. The publishers hold no securities of the Company. This marketing may increase investor awareness, trading volume, and share price, which may be temporary. Full disclaimers.

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.

Spotted something wrong? Report an error.